Non-covalent BTK inhibitor pirtobrutinib shows promise as frontline therapy for CLL/SLL
Non-covalent BTK inhibitor pirtobrutinib shows promise as frontline therapy for CLL/SLL
Linvoseltamab monotherapy in newly diagnosed multiple myeloma shows impressive frontline responses
Pimicotinib in TGCT demonstrates durable responses and sustained functional improvement
Latest in bladder cancer from the second half of 2025
IPSO guidelines on minimally invasive surgery in paediatric solid tumours
Principles and practice of prognostication
Avoiding burnout
Choosing Wisely: Managing resectable colorectal liver metastases
Common Sense Oncology: Socialist vs Capitalist Oncology
Optimal management of gastric cancers
Precision approaches to treating HPB cancers
I-DXd shows strong brain metastasis responses in extensive-stage small cell lung cancer with manageable safety